ASCO 2021 Highlights on Treatment-Naïve Higher-Risk MDS: CR/OS Data From VERONA Study on Venetoclax With Azacitidine
By
Yale Cancer Center
FEATURING
Amer Zeidan
By
Yale Cancer Center
FEATURING
Amer Zeidan
Login to view comments.
Click here to Login